LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 199 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $170,237,753 | -18.8% | 2,841,084 | -2.2% | 0.01% | -16.7% |
| Q2 2023 | $209,534,064 | +0.3% | 2,906,159 | +2.4% | 0.01% | 0.0% |
| Q1 2023 | $208,811,979 | +12.0% | 2,838,662 | +1.8% | 0.01% | 0.0% |
| Q4 2022 | $186,356,234 | -18.8% | 2,789,764 | +4.7% | 0.01% | -25.0% |
| Q3 2022 | $229,538,000 | -4.9% | 2,665,618 | -1.5% | 0.01% | 0.0% |
| Q2 2022 | $241,323,000 | -21.5% | 2,704,847 | -1.0% | 0.01% | 0.0% |
| Q1 2022 | $307,469,000 | -27.4% | 2,733,307 | -0.3% | 0.01% | -27.3% |
| Q4 2021 | $423,655,000 | +11.3% | 2,742,808 | +0.4% | 0.01% | 0.0% |
| Q3 2021 | $380,512,000 | +41.9% | 2,731,194 | +33.6% | 0.01% | +57.1% |
| Q2 2021 | $268,200,000 | -17.3% | 2,044,378 | -3.9% | 0.01% | -30.0% |
| Q1 2021 | $324,166,000 | +65.8% | 2,126,383 | +8.2% | 0.01% | +66.7% |
| Q4 2020 | $195,519,000 | -4.0% | 1,965,996 | -8.0% | 0.01% | -25.0% |
| Q3 2020 | $203,614,000 | -14.4% | 2,136,110 | +0.4% | 0.01% | -11.1% |
| Q2 2020 | $237,978,000 | +48.2% | 2,127,655 | -3.7% | 0.01% | +12.5% |
| Q1 2020 | $160,605,000 | -35.4% | 2,208,536 | -7.4% | 0.01% | -20.0% |
| Q4 2019 | $248,749,000 | +1.6% | 2,385,158 | -3.0% | 0.01% | 0.0% |
| Q3 2019 | $244,759,000 | -14.2% | 2,458,906 | -1.6% | 0.01% | -16.7% |
| Q2 2019 | $285,250,000 | -17.2% | 2,498,905 | -8.8% | 0.01% | -20.0% |
| Q1 2019 | $344,350,000 | -8.1% | 2,739,255 | -0.8% | 0.02% | -21.1% |
| Q4 2018 | $374,785,000 | -59.2% | 2,761,861 | -17.5% | 0.02% | -52.5% |
| Q3 2018 | $918,554,000 | +35.8% | 3,346,406 | +2.5% | 0.04% | +29.0% |
| Q2 2018 | $676,405,000 | +35.9% | 3,264,974 | +8.3% | 0.03% | +29.2% |
| Q1 2018 | $497,763,000 | +21.3% | 3,013,829 | +0.6% | 0.02% | +20.0% |
| Q4 2017 | $410,374,000 | +2.3% | 2,996,960 | +1.7% | 0.02% | 0.0% |
| Q3 2017 | $401,058,000 | +23.1% | 2,945,701 | +9.8% | 0.02% | +17.6% |
| Q2 2017 | $325,822,000 | +17.7% | 2,683,880 | +2.6% | 0.02% | +13.3% |
| Q1 2017 | $276,770,000 | +173969.2% | 2,614,993 | +166566.2% | 0.02% | – |
| Q4 2016 | $159,000 | -19.3% | 1,569 | -18.6% | 0.00% | – |
| Q3 2016 | $197,000 | -65.6% | 1,928 | -59.8% | 0.00% | -100.0% |
| Q2 2016 | $572,000 | +289.1% | 4,800 | +247.6% | 0.00% | – |
| Q1 2016 | $147,000 | +162.5% | 1,381 | +165.1% | 0.00% | – |
| Q4 2015 | $56,000 | -5.1% | 521 | -23.4% | 0.00% | – |
| Q3 2015 | $59,000 | -91.2% | 680 | -89.8% | 0.00% | -100.0% |
| Q2 2015 | $673,000 | +1194.2% | 6,671 | +883.9% | 0.00% | – |
| Q1 2015 | $52,000 | -26.8% | 678 | -49.3% | 0.00% | – |
| Q4 2014 | $71,000 | +173.1% | 1,336 | +144.7% | 0.00% | – |
| Q3 2014 | $26,000 | -23.5% | 546 | 0.0% | 0.00% | – |
| Q2 2014 | $34,000 | -20.9% | 546 | -13.2% | 0.00% | – |
| Q1 2014 | $43,000 | +87.0% | 629 | +43.3% | 0.00% | – |
| Q4 2013 | $23,000 | +15.0% | 439 | -6.2% | 0.00% | – |
| Q3 2013 | $20,000 | +11.1% | 468 | 0.0% | 0.00% | – |
| Q2 2013 | $18,000 | – | 468 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |